BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30290054)

  • 1. Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
    Gaowa S; Futamura M; Tsuneki M; Kamino H; Tajima JY; Mori R; Arakawa H; Yoshida K
    Cancer Sci; 2018 Dec; 109(12):3910-3920. PubMed ID: 30290054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible existence of lysosome-like organella within mitochondria and its role in mitochondrial quality control.
    Miyamoto Y; Kitamura N; Nakamura Y; Futamura M; Miyamoto T; Yoshida M; Ono M; Ichinose S; Arakawa H
    PLoS One; 2011 Jan; 6(1):e16054. PubMed ID: 21264221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells.
    Mitkin NA; Hook CD; Schwartz AM; Biswas S; Kochetkov DV; Muratova AM; Afanasyeva MA; Kravchenko JE; Bhattacharyya A; Kuprash DV
    Sci Rep; 2015 Mar; 5():9330. PubMed ID: 25786345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressing mitochondrial inner membrane protein (IMMT) inhibits the proliferation of breast cancer cells through mitochondrial remodeling and metabolic regulation.
    Liu L; Zhao Q; Xiong D; Li D; Du J; Huang Y; Yang Y; Chen R
    Sci Rep; 2024 Jun; 14(1):12766. PubMed ID: 38834715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis.
    Trinh DLN; Elwi AN; Kim SW
    Oncotarget; 2010 Oct; 1(6):396-404. PubMed ID: 21311096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mieap forms membrane-less organelles involved in cardiolipin metabolism.
    Ikari N; Honjo K; Sagami Y; Nakamura Y; Arakawa H
    iScience; 2024 Feb; 27(2):108916. PubMed ID: 38322995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LACTB is a tumour suppressor that modulates lipid metabolism and cell state.
    Keckesova Z; Donaher JL; De Cock J; Freinkman E; Lingrell S; Bachovchin DA; Bierie B; Tischler V; Noske A; Okondo MC; Reinhardt F; Thiru P; Golub TR; Vance JE; Weinberg RA
    Nature; 2017 Mar; 543(7647):681-686. PubMed ID: 28329758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Activity of KIF14, Mieap, and EZR in a New Type of the Invasive Component, Torpedo-Like Structures, Predetermines the Metastatic Potential of Breast Cancer.
    Gerashchenko TS; Zolotaryova SY; Kiselev AM; Tashireva LA; Novikov NM; Krakhmal NV; Cherdyntseva NV; Zavyalova MV; Perelmuter VM; Denisov EV
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells.
    Cheng RYS; Burkett S; Ambs S; Moody T; Wink DA; Ridnour LA
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers.
    Sano H; Futamura M; Gaowa S; Kamino H; Nakamura Y; Yamaguchi K; Tanaka Y; Yasufuku I; Nakakami A; Arakawa H; Yoshida K
    Biochem Biophys Res Commun; 2020 Aug; 529(3):582-589. PubMed ID: 32736677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer.
    Evans DG; van Veen EM; Byers HJ; Evans SJ; Burghel GJ; Woodward ER; Harkness EF; Eccles DM; Greville-Haygate SL; Ellingford JM; Bowers NL; Pereira M; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ
    J Med Genet; 2022 Feb; 59(2):115-121. PubMed ID: 33758026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of immune microenvironment in breast ductal carcinoma in situ.
    Toss MS; Abidi A; Lesche D; Joseph C; Mahale S; Saunders H; Kader T; Miligy IM; Green AR; Gorringe KL; Rakha EA
    Br J Cancer; 2020 May; 122(10):1496-1506. PubMed ID: 32203210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
    Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
    Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic landscape of ductal carcinoma in situ and association with progression.
    Lin CY; Vennam S; Purington N; Lin E; Varma S; Han S; Desa M; Seto T; Wang NJ; Stehr H; Troxell ML; Kurian AW; West RB
    Breast Cancer Res Treat; 2019 Nov; 178(2):307-316. PubMed ID: 31420779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive multigene mutation spectra of breast cancer patients from Northeast China obtained using the Ion Torrent sequencing platform.
    Fan C; Liu N; Fan S; Yang Z; Ye N; Wang K
    Oncol Rep; 2019 Oct; 42(4):1580-1588. PubMed ID: 31364747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
    Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
    Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.
    Done SJ; Arneson NC; Ozçelik H; Redston M; Andrulis IL
    Cancer Res; 1998 Feb; 58(4):785-9. PubMed ID: 9485035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Alterations during the
    Trinh A; Gil Del Alcazar CR; Shukla SA; Chin K; Chang YH; Thibault G; Eng J; Jovanović B; Aldaz CM; Park SY; Jeong J; Wu C; Gray J; Polyak K
    Mol Cancer Res; 2021 Apr; 19(4):623-635. PubMed ID: 33443130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline
    Evans DG; Woodward ER; Bajalica-Lagercrantz S; Oliveira C; Frebourg T
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.